PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
110 hedge funds and large institutions have $255M invested in Paratek Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 46 increasing their positions, 30 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
21% less capital invested
Capital invested by funds: $324M → $255M (-$68.3M)
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
Holders
110
Holding in Top 10
3
Calls
$2.31M
Puts
$2.9M
Top Buyers
| 1 | +$9.78M | |
| 2 | +$6.97M | |
| 3 | +$5.66M | |
| 4 |
AC
Armistice Capital
New York
|
+$5.63M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.8M |
Top Sellers
| 1 | -$16.2M | |
| 2 | -$9.62M | |
| 3 | -$6.21M | |
| 4 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$5.84M |
| 5 |
OP
Omni Partners
London,
United Kingdom
|
-$2.01M |